PERRIGO CO PLC (PRGO) Stock Fundamental Analysis

NYSE:PRGO • IE00BGH1M568

14.54 USD
+0.16 (+1.11%)
At close: Feb 13, 2026
14.54 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRGO. PRGO was compared to 191 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PRGO while its profitability can be described as average. PRGO has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • PRGO had positive earnings in the past year.
  • In the past year PRGO had a positive cash flow from operations.
  • In the past 5 years PRGO always reported negative net income.
  • Each year in the past 5 years PRGO had a positive operating cash flow.
PRGO Yearly Net Income VS EBIT VS OCF VS FCFPRGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

  • PRGO's Return On Assets of -0.51% is fine compared to the rest of the industry. PRGO outperforms 77.49% of its industry peers.
  • Looking at the Return On Equity, with a value of -1.16%, PRGO is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
  • PRGO's Return On Invested Capital of 3.48% is amongst the best of the industry. PRGO outperforms 81.68% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PRGO is significantly below the industry average of 12.64%.
  • The 3 year average ROIC (2.21%) for PRGO is below the current ROIC(3.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.51%
ROE -1.16%
ROIC 3.48%
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
PRGO Yearly ROA, ROE, ROICPRGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Operating Margin, with a value of 9.18%, PRGO belongs to the top of the industry, outperforming 81.68% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PRGO has grown nicely.
  • PRGO has a Gross Margin (35.46%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of PRGO has remained more or less at the same level.
Industry RankSector Rank
OM 9.18%
PM (TTM) N/A
GM 35.46%
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
PRGO Yearly Profit, Operating, Gross MarginsPRGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

  • PRGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • PRGO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PRGO has more shares outstanding
  • PRGO has a better debt/assets ratio than last year.
PRGO Yearly Shares OutstandingPRGO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
PRGO Yearly Total Debt VS Total AssetsPRGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.66, we must say that PRGO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.66, PRGO is in line with its industry, outperforming 52.36% of the companies in the same industry.
  • The Debt to FCF ratio of PRGO is 13.43, which is on the high side as it means it would take PRGO, 13.43 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 13.43, PRGO is in the better half of the industry, outperforming 78.53% of the companies in the same industry.
  • PRGO has a Debt/Equity ratio of 0.81. This is a neutral value indicating PRGO is somewhat dependend on debt financing.
  • The Debt to Equity ratio of PRGO (0.81) is worse than 70.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 13.43
Altman-Z 0.66
ROIC/WACC0.42
WACC8.35%
PRGO Yearly LT Debt VS Equity VS FCFPRGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • PRGO has a Current Ratio of 2.51. This indicates that PRGO is financially healthy and has no problem in meeting its short term obligations.
  • PRGO has a Current ratio (2.51) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.44 indicates that PRGO should not have too much problems paying its short term obligations.
  • PRGO has a Quick ratio of 1.44. This is in the lower half of the industry: PRGO underperforms 63.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.44
PRGO Yearly Current Assets VS Current LiabilitesPRGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

  • PRGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.47%, which is quite good.
  • The Earnings Per Share has been decreasing by -8.68% on average over the past years.
  • Looking at the last year, PRGO shows a decrease in Revenue. The Revenue has decreased by -2.51% in the last year.
  • The Revenue has been growing slightly by 2.48% on average over the past years.
EPS 1Y (TTM)16.47%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-4.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.21% on average over the next years.
  • Based on estimates for the next years, PRGO will show a decrease in Revenue. The Revenue will decrease by -0.41% on average per year.
EPS Next Y10.45%
EPS Next 2Y2.68%
EPS Next 3Y3.4%
EPS Next 5Y5.21%
Revenue Next Year-4.31%
Revenue Next 2Y-2.99%
Revenue Next 3Y-1.56%
Revenue Next 5Y-0.41%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRGO Yearly Revenue VS EstimatesPRGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
PRGO Yearly EPS VS EstimatesPRGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.01 indicates a rather cheap valuation of PRGO.
  • Based on the Price/Earnings ratio, PRGO is valued cheaply inside the industry as 96.86% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of PRGO to the average of the S&P500 Index (26.68), we can say PRGO is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.39, the valuation of PRGO can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PRGO indicates a rather cheap valuation: PRGO is cheaper than 95.29% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of PRGO to the average of the S&P500 Index (28.06), we can say PRGO is valued rather cheaply.
Industry RankSector Rank
PE 5.01
Fwd PE 5.39
PRGO Price Earnings VS Forward Price EarningsPRGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRGO indicates a rather cheap valuation: PRGO is cheaper than 93.72% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, PRGO is valued cheaply inside the industry as 94.76% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.37
EV/EBITDA 7.19
PRGO Per share dataPRGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • PRGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PRGO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y2.68%
EPS Next 3Y3.4%

6

5. Dividend

5.1 Amount

  • PRGO has a Yearly Dividend Yield of 8.07%, which is a nice return.
  • PRGO's Dividend Yield is rather good when compared to the industry average which is at 1.18. PRGO pays more dividend than 98.95% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, PRGO pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.07%

5.2 History

  • On average, the dividend of PRGO grows each year by 6.29%, which is quite nice.
  • PRGO has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of PRGO decreased recently.
Dividend Growth(5Y)6.29%
Div Incr Years1
Div Non Decr Years1
PRGO Yearly Dividends per sharePRGO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • PRGO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of PRGO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-306.95%
EPS Next 2Y2.68%
EPS Next 3Y3.4%
PRGO Yearly Income VS Free CF VS DividendPRGO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

PERRIGO CO PLC

NYSE:PRGO (2/13/2026, 8:04:00 PM)

After market: 14.54 0 (0%)

14.54

+0.16 (+1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05
Earnings (Next)02-26
Inst Owners112.1%
Inst Owner Change-96.18%
Ins Owners0.45%
Ins Owner Change1.57%
Market Cap2.00B
Revenue(TTM)4.28B
Net Income(TTM)-51.80M
Analysts76
Price Target19.04 (30.95%)
Short Float %10.18%
Short Ratio3.97
Dividend
Industry RankSector Rank
Dividend Yield 8.07%
Yearly Dividend1.12
Dividend Growth(5Y)6.29%
DP-306.95%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-5.82%
Max EPS beat(2)3.97%
EPS beat(4)2
Avg EPS beat(4)1.04%
Min EPS beat(4)-5.82%
Max EPS beat(4)7.44%
EPS beat(8)5
Avg EPS beat(8)5.08%
EPS beat(12)9
Avg EPS beat(12)6.13%
EPS beat(16)10
Avg EPS beat(16)2.06%
Revenue beat(2)0
Avg Revenue beat(2)-5.54%
Min Revenue beat(2)-6.76%
Max Revenue beat(2)-4.32%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-6.76%
Max Revenue beat(4)-4.32%
Revenue beat(8)0
Avg Revenue beat(8)-5.24%
Revenue beat(12)0
Avg Revenue beat(12)-4.82%
Revenue beat(16)1
Avg Revenue beat(16)-3.87%
PT rev (1m)0%
PT rev (3m)-41.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.16%
Valuation
Industry RankSector Rank
PE 5.01
Fwd PE 5.39
P/S 0.47
P/FCF 7.37
P/OCF 5.33
P/B 0.45
P/tB N/A
EV/EBITDA 7.19
EPS(TTM)2.9
EY19.94%
EPS(NY)2.7
Fwd EY18.56%
FCF(TTM)1.97
FCFY13.56%
OCF(TTM)2.73
OCFY18.78%
SpS31.11
BVpS32.31
TBVpS-9.62
PEG (NY)0.48
PEG (5Y)N/A
Graham Number45.92
Profitability
Industry RankSector Rank
ROA -0.51%
ROE -1.16%
ROCE 4.4%
ROIC 3.48%
ROICexc 3.65%
ROICexgc 11.35%
OM 9.18%
PM (TTM) N/A
GM 35.46%
FCFM 6.34%
ROA(3y)-1.06%
ROA(5y)-1.05%
ROE(3y)-2.38%
ROE(5y)-2.27%
ROIC(3y)2.21%
ROIC(5y)2.9%
ROICexc(3y)2.37%
ROICexc(5y)3.33%
ROICexgc(3y)9.14%
ROICexgc(5y)12.63%
ROCE(3y)2.79%
ROCE(5y)3.67%
ROICexgc growth 3Y-27.17%
ROICexgc growth 5Y8.08%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y10.11%
OM growth 3Y-22.79%
OM growth 5Y3.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y-0.98%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 13.43
Debt/EBITDA 4.98
Cap/Depr 31.43%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 51.81%
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 1.44
Altman-Z 0.66
F-Score5
WACC8.35%
ROIC/WACC0.42
Cap/Depr(3y)31.02%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.35%
Cap/Sales(5y)3.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.47%
EPS 3Y7.69%
EPS 5Y-8.68%
EPS Q2Q%-1.23%
EPS Next Y10.45%
EPS Next 2Y2.68%
EPS Next 3Y3.4%
EPS Next 5Y5.21%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y1.86%
Revenue growth 5Y2.48%
Sales Q2Q%-4.06%
Revenue Next Year-4.31%
Revenue Next 2Y-2.99%
Revenue Next 3Y-1.56%
Revenue Next 5Y-0.41%
EBIT growth 1Y65.28%
EBIT growth 3Y-21.35%
EBIT growth 5Y6.28%
EBIT Next Year32.15%
EBIT Next 3Y9.6%
EBIT Next 5Y7.6%
FCF growth 1Y-6.93%
FCF growth 3YN/A
FCF growth 5Y19.35%
OCF growth 1Y-1.83%
OCF growth 3Y32.42%
OCF growth 5Y-1.32%

PERRIGO CO PLC / PRGO FAQ

What is the ChartMill fundamental rating of PERRIGO CO PLC (PRGO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to PRGO.


Can you provide the valuation status for PERRIGO CO PLC?

ChartMill assigns a valuation rating of 9 / 10 to PERRIGO CO PLC (PRGO). This can be considered as Undervalued.


What is the profitability of PRGO stock?

PERRIGO CO PLC (PRGO) has a profitability rating of 6 / 10.


What is the earnings growth outlook for PERRIGO CO PLC?

The Earnings per Share (EPS) of PERRIGO CO PLC (PRGO) is expected to grow by 10.45% in the next year.


Can you provide the dividend sustainability for PRGO stock?

The dividend rating of PERRIGO CO PLC (PRGO) is 6 / 10 and the dividend payout ratio is -306.95%.